“Calcitonin gene-related peptide (CGRP), substance-P and dural mast cells are main contributors in neurogenic inflammation underlying migraine pathophysiology.
Modulation of endocannabinoid system attenuates migraine pain, but its mechanisms of action remains unclear.
We investigated receptor mechanisms mediating anti-neuroinflammatory effects of endocannabinoid system modulation in in-vivo migraine model and ex-vivo hemiskull preparations in rats.
Selective ligands targeting CB1 and CB2 receptors may provide novel and effective treatment strategies against migraine.”